Anika Therapeutics, Inc.

Iolab Corporation

Hughes Aircraft Company

Gooding, Tamera B.

Charles H Sherwood

Stephen J Kennedy

Jing-Wen Kuo

Khalid K Sadozai

Tamera B Gooding

Bruce A Tunberg

Paul C A Bulpitt

Walker L Gordy

Paul D Rice

Jing-wen Kuo

Kyle Bui

Paul C Bulpitt

A method of treating a subject having a musculoskeletal disorder includes administering to a subject's articular site in need thereof an effective amount of a hyaluronic acid (HA) composition. In one embodiment, the HA composition includes an HA derivative, wherein carboxyl functionalities of the hyaluronic acid derivative are each independently derivatized to include an N-acylurea or O-acyl isourea, or both N-acylurea and O-acyl isourea. In another embodiment, the HA composition includes a crosslinked HA gel that is prepared by reacting an uncrosslinked HA with a biscarbodiimide in the presence of pH buffer in a range of between about 4 and about 8. The composite can optionally include at least one second bioactive agent other than the HA derivative, such as a steroid.

Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid

Disclosed are hyaluronic acid (HA) compositions including crosslinked, water-insoluble, hydrated HA gel particles. Also disclosed are methods of making the HA compositions, and methods of using the HA composition to augment tissue in a subject.

Crosslinked hyaluronic acid compositions for tissue augmentation

The present invention relates to biscarbodiimides, thiourea derivatives, urea derivatives, and cross-linked hyaluronan derivatives having at least one intramolecular disulfide bond, and methods of preparation thereof. The invention also includes thiolated hyaluronan derivatives and salts thereof having at least one pendant thiol group or a modified pendant thiol group, and methods of preparation thereof. An example of a modified pendant thiol group is a sulfhydryl group linked to a small molecule such as a bioactive agent, for example a drug or pharmaceutically active moiety. A hyaluronan derivative having a sulfhydryl group linked to a pharmaceutically active moiety is useful as a sustained or controlled release drug delivery vehicle. Compositions containing the hyaluronan derivatives of the invention can reversibly viscosify in vivo or in vitro, in response to mild changes in condition, and are thus useful in ophthalmic surgery and in tissue engineering.

Thiol-modified hyaluronan

The present invention relates to a composite and a method for reducing post-operative adhesion of tissues. The composite includes a biocompatible, biodegradable support, and a water-insoluble hyaluronic acid derivative at the support. The hyaluronic acid derivative includes an N-acylurea that results from cross-linking by the reaction of hyaluronic acid with a multifunctional carbodiimide. Optionally, a monocarbodiimide also may be employed. A pharmaceutically-active molecule may be added to the N-acylurea derivative of hyaluronic acid. Although the composite includes material that prevents adhesion between tissues, in order to reduce the need for suturing when the composite is being used during a surgical procedure, a material that enhances adhesion of the composite to tissues may be applied to a surface of the composite. A method of forming the composite for reducing post-operative adhesion of tissues, including the step of applying an N-acylurea derivative of hyaluronic acid resulting from cross-linking with a multifunctional carbodiimide, to a biocompatible, biodegradable support; a method of preparing a drug delivery vehicle that includes a pharmaceutically-active molecule with the N-acylurea derivative of hyaluronic acid resulting from cross-linking with a multifunctional carbodiimide; and a method of reducing post-operative adhesion of tissues are disclosed.

Bioabsorbable composites of derivatized hyaluronic acid and other biodegradable, biocompatible polymers

The polymethyl methacrylate (PMMA) or copolymer thereof used to produce one-piece intraocular lenses is modified by a compression molding process to produce a much tougher material with improved mechanical properties. The process takes material in rod form and compresses into lens blanks. The molded lens blanks receive little or no compression strain in the center 4 mm optic zone. The compression is limited to the periphery region outside the center 4 mm zone. The intraocular lens fabricated from the molded lens blank exhibits greatly increased haptic mechanical properties and resistance to breakage.

Method of making an intraocular lens with fracture resistant haptics

Intraocular lens with fracture resistant haptics

An improved intraocular lens has at least one filamentary haptic composed of a continuous matrix material interspersed with a toughening amount of discrete particles of a multistage, sequentially produced elastomeric polymer. An improved process for preparing a single-piece intraocular lens involves preparing a composite lens blank by molding pellets composed of a continuous polymeric material interspersed with particles of a multistage, sequentially produced elastomeric polymer about a central optic lens core so as to produce a single lens blank having a toughened annular region surrounding the central optic region, and then machining at least one filamentary haptic from the toughened annular region to prepare the lens.

Method of making an intraocular lens with resilient haptics

An improved intraocular lens is disclosed with at least one filamentary haptic composed of a continuous matrix material interspersed with a toughening amount of discrete particles of a multistage, sequentially produced elastomeric polymer. An improved process for preparing a single-piece intraocular lens is also disclosed. The process involves preparing a composite lens blank by molding pellets composed of a continuous polymeric material interspersed with particles of a multistage, sequentially produced elastomeric polymer about a central optic lens core so as to produce a single lens blank having a toughened annular region surrounding the central optic region, and then machining at least one filamentary haptic from the toughened annular region to prepare the lens.

Intraocular lens with resilient haptics

A flexible, air permeable composite highly effective as a highly absorbent fiber filter, suitable for high throughput, low pressure drop applications. The composites and filters use a non-woven fabric substrate, in conjunction with organic polymer fibers, such as polypropylene fibers, formed in-situ from a solvent solution of the polymer, with solid particles such as carbon particles interstitially positioned within the mass, and forming a unique microstructure by the interaction of the flexible non-woven fibers and the polymer fibers. A method of entrapping small sorptive particles within such filters is also provided.

Growing community of inventors

Sudbury, MA, United States of America

Charles H Sherwood